Delivery Order SPE2DX22D0129-SPE2D826F0DGN
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $124,469.46 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 14, 2026, represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,141.37 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and competitively awarded on a firm fixed-price basis, will be completed by January 20, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $93,276.40 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $14,995.35 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order, which utilized no set-aside designation, represents a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the awardee's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $49,779.00 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract is scheduled for completion by January 20, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $58,185.03 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and no set-aside designation was used. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $597,479.59 on January 16, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a child contract with no set-aside designation, awarded on a competitive basis. The awardee, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DGNDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $109,351.92 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on January 20, 2026, with performance occurring at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle. This contract aligns with the Defense Logistics Agency's pharmaceutical procurement strategy to supply military healthcare systems worldwide with essential medical commodities. Amerisourcebergen's IDC encompasses a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its significant existing contract vehicle, positions it to serve critical customers including the Defense Health Agency and U.S. Coast Guard, supporting military treatment facilities and veterans' healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $109.4k | 1/18/26 |